Regulatory/EMA/FDA/PMDA Archives

November 27, 2024

A computational tool to optimize clinical trial parameter selection in Duchenne muscular dystrophy: A practical guide and case studies

Duchenne muscular dystrophy (DMD), a rare pediatric disease, presents numerous challenges when designing clinical trials...

April 9, 2025-April 10, 2025

On April 9-10, 2025, the 2025 Clinical Outcome Assessment...

September 30, 2024

Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction...

October 8, 2024

Estelle Haenel, Celeste A. Elash, Katie Garner, Megan Turner, Scottie KernAbstract Electronic Clinical Outcome Assessment (eCOA) C

October 1, 2024

Note: You are reading this information because Critical Path Institute is a partner of both ERA4TB and Unite4TB.

September 30, 2024

C-Path announced the formation of a new task for under its RDCA-DAP, dedicated to...

September 19, 2024

C-Path is thrilled to announce its PKDOC has been awarded...

October 23, 2024-October 27, 2024

BmDR Oversight Committee members Nicholas King, Katrina Peron, and Gary Friedman will be attending ASN Kidney Week 2024 in San..

August 22, 2024

C-Path proudly announced today a $250,000 grant award to Peter Wipf, Ph.D...

The following originally appeared on fda.gov: Summary: The Food and Drug Administration is announcing the following public worksho